Struggling to get a universal meningococcal vaccine and novel uses for bacterial toxins in cancer treatment

Microb Biotechnol. 2010 Jul;3(4):359-61. doi: 10.1111/j.1751-7915.2010.00195.x.

Authors

Craig Daniels¹, Tino Krell, Carmen Michán, Juan L Ramos

Affiliation

¹ Structural Proteomics in Toronto, UHN and University of Toronto, Banting and Best Department of Medical Research, C.H. Best Institute, 112 College Street, M5G 1L6, Toronto, Ontario, Canada.

No abstract available

MeSH terms

Antineoplastic Agents / therapeutic use*
Biotechnology / methods*
Communicable Diseases / diagnosis*
Humans
Meningococcal Vaccines / genetics
Meningococcal Vaccines / immunology*
Microarray Analysis / methods*
Organisms, Genetically Modified
Shiga Toxin / therapeutic use*

Substances

Antineoplastic Agents
Meningococcal Vaccines
Shiga Toxin